Sumitomo Mitsui Trust Group’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.1M | Sell |
|
|||||
|
2025
Q1 | $20.1M | Sell |
|
|||||
|
2024
Q4 | $34.9M | Sell |
|
|||||
|
2024
Q3 | $64.7M | Sell |
|
|||||
|
2024
Q2 | $72.9M | Sell |
|
|||||
|
2024
Q1 | $93.5M | Sell |
|
|||||
|
2023
Q4 | $106M | Sell |
|
|||||
|
2023
Q3 | $111M | Buy |
|
|||||
|
2023
Q2 | $138M | Buy |
|
|||||
|
2023
Q1 | $116M | Buy |
|
|||||
|
2022
Q4 | $104M | Buy |
|
|||||
|
2022
Q3 | $166M | Buy |
|
|||||
|
2022
Q2 | $144M | Sell |
|
|||||
|
2022
Q1 | $209M | Buy |
|
|||||
|
2021
Q4 | $326M | Buy |
|
|||||
|
2021
Q3 | $322M | Sell |
|
|||||
|
2021
Q2 | $506M | Sell |
|
|||||
|
2021
Q1 | $386M | Sell |
|
|||||
|
2020
Q4 | $278M | Sell |
|
|||||
|
2020
Q3 | $121M | Sell |
|
|||||
|
2020
Q2 | $130M | Sell |
|
|||||
|
2020
Q1 | $86.7M | Sell |
|
|||||
|
2019
Q4 | $105M | Sell |
|
|||||
|
2019
Q3 | $96.7M | Buy |
|
|||||
|
2019
Q2 | $36.3M | Buy |
|
|||||
|
2019
Q1 | $17.9M | Buy |
|